A Simple Model to Predict Moderate to Severe Steatosis in Obese Liver Donors

Abstract

Background: In the selection of marginal liver grafts most transplantation centers use a cut-off of 30% macrovesicular steatosis to define an acceptable risk of non-function. The aim of this prospective cohort study was to create a noninvasive model to predict >30% hepatic steatosis based on simple clinical and biochemical markers available at the time of potential liver-donor evaluation, to avoid futile and expensive procurement proceedings.